...
首页> 外文期刊>Breast care >Reproductive Factors, Steroid Receptor Status,and Tumour Markers of HER2-Positive Breast Cancer inNorthern China
【24h】

Reproductive Factors, Steroid Receptor Status,and Tumour Markers of HER2-Positive Breast Cancer inNorthern China

机译:中国北方地区HER2阳性乳腺癌的生殖因子,类固醇受体状态和肿瘤标志物

获取原文
获取原文并翻译 | 示例

摘要

Background: Although China has a breast cancer incidence that surpasses all other cancer registries, there have been few reports to evaluate the relationships of reproductive history, steroid receptor status, and tumour markers with HER2 status of breast cancer. Patients and Methods: This project included 274 primary invasive ductal breast cancer patients. Information concerning the reproductive factors and tumour characteristics of the patients had previously been collected. HER2 and steroid receptor status were detected in tumour tissues. Serum CEA, CA15-3, and CA125 levels were analyzed for all patients. Results: Younger age at menarche was observed in patients with HER2-positive than in those with HER2-negative status (p = 0.03). Statistically significant differences were found between the HER2-positive group and HER2-negative group for estrogen receptor (ER) and progesterone receptor (PR) status (p < 0.01). Age of onset, other reproductive factors, tumour characteristics, and serum tumour marker level were not significantly different between those patients with HER2-positive and those with HER2-negative status. Conclusion: We confirm that age at menarche may plausibly be differentially correlated with the risk of HER2-positive invasive ductal breast cancer because it is presumed to impact exposure to endogenous sex hormones. HER2 is inversely related to ER and PR in invasive ductal breast cancer patients of Northern China.
机译:背景:尽管中国的乳腺癌发病率超过所有其他癌症登记册,但很少有报道评估生殖史,类固醇受体状态和肿瘤标志物与乳腺癌的HER2状态之间的关系。患者和方法:该项目包括274名原发性浸润性导管癌患者。先前已收集了有关患者生殖因子和肿瘤特征的信息。在肿瘤组织中检测到HER2和类固醇受体状态。对所有患者的血清CEA,CA15-3和CA125水平进行了分析。结果:HER2阳性患者的初潮年龄要比HER2阴性患者的年轻(p = 0.03)。雌激素受体(ER)和孕激素受体(PR)的状态在HER2阳性组和HER2阴性组之间存在统计学差异(p <0.01)。 HER2阳性患者与HER2阴性患者的发病年龄,其他生殖因素,肿瘤特征和血清肿瘤标志物水平无显着差异。结论:我们证实,初潮年龄可能与HER2阳性浸润性导管癌的风险存在差异,因为推测这可能会影响内源性激素的暴露。 HER2与华北地区浸润性导管癌患者的ER和PR呈负相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号